450 related articles for article (PubMed ID: 24826816)
1. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
[TBL] [Abstract][Full Text] [Related]
2. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
Ronga L; Del Favero M; Cohen A; Soum C; Le Pape P; Savrimoutou S; Pinaud N; Mullié C; Daulouede S; Vincendeau P; Farvacques N; Agnamey P; Pagniez F; Hutter S; Azas N; Sonnet P; Guillon J
Eur J Med Chem; 2014 Jun; 81():378-93. PubMed ID: 24858543
[TBL] [Abstract][Full Text] [Related]
4. In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of structure/activity relationships.
Iwatsuki M; Otoguro K; Ishiyama A; Namatame M; Nishihara-Tukashima A; Hashida J; Nakashima T; Masuma R; Takahashi Y; Yamada H; Omura S
J Antibiot (Tokyo); 2010 Oct; 63(10):619-22. PubMed ID: 20717119
[No Abstract] [Full Text] [Related]
5. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of Trypanosoma brucei active 1-alkyloxy and 1-benzyloxyadamantano 2-guanylhydrazones.
Papanastasiou I; Tsotinis A; Zoidis G; Kolocouris N; Prathalingam SR; Kelly JM
ChemMedChem; 2009 Jul; 4(7):1059-62. PubMed ID: 19422003
[TBL] [Abstract][Full Text] [Related]
7. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.
Venkatraj M; Ariën KK; Heeres J; Joossens J; Dirié B; Lyssens S; Michiels J; Cos P; Lewi PJ; Vanham G; Maes L; Van der Veken P; Augustyns K
Bioorg Med Chem; 2014 Oct; 22(19):5241-8. PubMed ID: 25199582
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents.
Ding D; Meng Q; Gao G; Zhao Y; Wang Q; Nare B; Jacobs R; Rock F; Alley MR; Plattner JJ; Chen G; Li D; Zhou H
J Med Chem; 2011 Mar; 54(5):1276-87. PubMed ID: 21322634
[TBL] [Abstract][Full Text] [Related]
9. Bistacrines as potential antitrypanosomal agents.
Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.
Vodnala SK; Lundbäck T; Yeheskieli E; Sjöberg B; Gustavsson AL; Svensson R; Olivera GC; Eze AA; de Koning HP; Hammarström LG; Rottenberg ME
J Med Chem; 2013 Dec; 56(24):9861-73. PubMed ID: 24283924
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antitrypanosomal activitiy of two microbial metabolites, KS-505a and alazopeptin.
Ishiyama A; Otoguro K; Namatame M; Nishihara A; Furusawa T; Masuma R; Shiomi K; Takahashi Y; Ichimura M; Yamada H; Omura S
J Antibiot (Tokyo); 2008 Oct; 61(10):627-32. PubMed ID: 19168977
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of α-phenoxy-N-sulfonylphenyl acetamides as Trypanosoma brucei Leucyl-tRNA synthetase inhibitors.
Xin W; Li Z; Wang Q; Du J; Zhu M; Zhou H
Eur J Med Chem; 2020 Jan; 185():111827. PubMed ID: 31732256
[TBL] [Abstract][Full Text] [Related]
13. Anti-trypanosomal activity of doubly modified salinomycin derivatives.
Antoszczak M; Steverding D; Sulik M; Janczak J; Huczyński A
Eur J Med Chem; 2019 Jul; 173():90-98. PubMed ID: 30986574
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of the trypanocidal diamidine DAPI on animal-infective Trypanosoma brucei brucei.
Borowy NK; Fink E; Hirumi H
Acta Trop; 1985 Dec; 42(4):287-98. PubMed ID: 2868631
[TBL] [Abstract][Full Text] [Related]
15. New heterocyclic compounds: Synthesis and antitrypanosomal properties.
Pomel S; Dubar F; Forge D; Loiseau PM; Biot C
Bioorg Med Chem; 2015 Aug; 23(16):5168-74. PubMed ID: 25835356
[TBL] [Abstract][Full Text] [Related]
16. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis.
Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR
Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377
[TBL] [Abstract][Full Text] [Related]
17. In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
Merschjohann K; Steverding D
Exp Parasitol; 2008 Apr; 118(4):637-40. PubMed ID: 18226810
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against Trypanosoma brucei and Trypanosoma cruzi.
Velásquez AM; Francisco AI; Kohatsu AA; Silva FA; Rodrigues DF; Teixeira RG; Chiari BG; de Almeida MG; Isaac VL; Vargas MD; Cicarelli RM
Bioorg Med Chem Lett; 2014 Apr; 24(7):1707-10. PubMed ID: 24630563
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
Nwodo NJ; Brun R; Osadebe PO
J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
